Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Salah‐Eddin Al‐Batran | Researchclopedia

Back to researchers

Salah‐Eddin Al‐Batran

Goethe University Frankfurt ORCID

366

Works

17,591

Citations

53

h-index

150

i10-index

Research Topics

Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Gastrointestinal Tumor Research and Treatment

Affiliations

Goethe University Frankfurt2004–2025

Boehringer Ingelheim (Germany)2010–2010

University of Bonn2006–2006

Universität Hamburg2004–2009

Johannes Gutenberg University Mainz2006–2006

Top Works

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah‐Eddin Al‐Batran,Nils Homann,et al.

20192,487 citations

Esophageal Cancer Research and Treatment

Lung Cancer Treatments and Mutations

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

Volker Heinemann,Ludwig Fischer von Weikersthal,et al.

20141,721 citations

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara,Mustafa Özgüroğlu,et al.

20181,309 citations

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164

Dung T. Le,Tae Won Kim,et al.

2019989 citations

Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

Salah‐Eddin Al‐Batran,J. T. Hartmann,et al.

2008781 citations

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

Salah‐Eddin Al‐Batran,Ralf‐Dieter Hofheinz,et al.

2016720 citations

Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer

Salah‐Eddin Al‐Batran,Nils Homann,et al.

2017465 citations

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial

Sebastian Stintzing,Dominik Paul Modest,et al.

2016411 citations

Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis

Yelena Y. Janjigian,Dominique Werner,et al.

2012364 citations